The Clinical Outcome of Patients with Refractory/Relapsed Lymphoid Blastic Phase of Chronic Myeloid Leukemia Treated with CAR T-Cells Therapy

被引:0
|
作者
Liu, Yujie [1 ,2 ]
Tu, Yuqing [1 ,2 ]
Xiao, Jinyan [1 ,2 ]
Shen, Yifan [2 ]
Zhou, Biqi [1 ,2 ]
Yang, Qiannan [1 ,2 ]
Liu, Tianhui [1 ,2 ]
Qi, Lijuan [1 ,2 ]
Chen, Jia [1 ,2 ]
Yu, Lei [3 ]
Wu, Depei [1 ,2 ]
Yang, Xu [1 ,2 ]
机构
[1] Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China
[3] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
关键词
D O I
10.1182/blood-2023-190741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
    Muehleck, Regina
    Scholl, Sebastian
    Hilgendorf, Inken
    Schrenk, Karin
    Hammersen, Jakob
    Frietsch, Jochen J.
    Fleischmann, Maximilian
    Sayer, Herbert G.
    Glaser, Anita
    Hochhaus, Andreas
    Schnetzke, Ulf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2539 - 2548
  • [22] Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
    Regina Mühleck
    Sebastian Scholl
    Inken Hilgendorf
    Karin Schrenk
    Jakob Hammersen
    Jochen J. Frietsch
    Maximilian Fleischmann
    Herbert G. Sayer
    Anita Glaser
    Andreas Hochhaus
    Ulf Schnetzke
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2539 - 2548
  • [23] Favorable transplantation outcome of patients with de novo chronic myeloid leukemia in blast phase (lymphoid and myeloid)
    Sasaki, Koji
    CANCER, 2025, 131 (01)
  • [24] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [25] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [26] Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features
    J A Woyach
    G Lozanski
    A S Ruppert
    A Lozanski
    K A Blum
    J A Jones
    J M Flynn
    A J Johnson
    M R Grever
    N A Heerema
    J C Byrd
    Leukemia, 2012, 26 : 1442 - 1444
  • [27] Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features
    Woyach, J. A.
    Lozanski, G.
    Ruppert, A. S.
    Lozanski, A.
    Blum, K. A.
    Jones, J. A.
    Flynn, J. M.
    Johnson, A. J.
    Grever, M. R.
    Heerema, N. A.
    Byrd, J. C.
    LEUKEMIA, 2012, 26 (06) : 1442 - 1444
  • [28] Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome
    Taga, Takashi
    Saito, Akiko Moriya
    Kudo, Kazuko
    Tomizawa, Daisuke
    Terui, Kiminori
    Moritake, Hiroshi
    Kinoshita, Akitoshi
    Iwamoto, Shotaro
    Nakayama, Hideki
    Takahashi, Hiroyuki
    Tawa, Akio
    Shimada, Akira
    Taki, Tomohiko
    Kigasawa, Hisato
    Koh, Katsuyoshi
    Adachi, Souichi
    BLOOD, 2012, 120 (09) : 1810 - 1815
  • [29] Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia
    Jain, Nitin
    Maiti, Abhishek
    Ravandi, Farhad
    Konopleva, Marina
    Daver, Naval
    Kadia, Tapan
    Pemmaraju, Naveen
    Short, Nicholas
    Kebriaei, Partow
    Ning, Jing
    Cortes, Jorge
    Jabbour, Elias
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : 1000 - 1007
  • [30] The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia
    Aksu, Tekin
    Unal, Sule
    Gurmuk, Fatma
    TURKISH JOURNAL OF PEDIATRICS, 2020, 62 (03) : 479 - 481